Lab Information
Talat Bessissow (MD/PhD)
Associate InvestigatorClinical Research Unit
Department of Medicine (McGill)
Research Profile
Keywords
Crohn's disease • ulcerative colitis • mucosal healing • neoplasia • pathogenesisResearch Interests
My research focuses on the role of mucosal healing in the treatment of inflammatory bowel diseases. I am also looking at identifying factor that predict disease relapse.Team Members
| Name | Position |
|---|
Latest Publications
- Shehab, M., Alrashed, F., Heron, V., Restellini, S. & Bessissow, T. (2022). Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Inflammatory bowel diseases.
- Hahn, G. D., Wetwittayakhlang, P., Afif, W., Bessissow, T. & Lakatos, P. L. (2022). Hereditary Nonpolyposis Colorectal Cancer in Association with Crohn's Disease and Lynch Syndrome: The Importance of a Strict Endoscopic Surveillance. Case reports in gastroenterology, vol. 16, p. 116-121.
- Hahn, G. D., Golovics, P. A., Wetwittayakhlang, P., Al Khoury, A., Bessissow, T. & Lakatos, P. L. (2022). Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?. Biomedicines, vol. 10.
- Xiao, Y., Benoit, N., Sedano, R., Jairath, V., Narula, N., McCurdy, J. D., Rosenfeld, G., Afif, W., Lakatos, P. L. & Bessissow, T. (2022). Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series. Digestive diseases and sciences.
- Golovics, P. A., Verdon, C., Wetwittayakhlang, P., Filliter, C., Gonczi, L., Hahn, G. D., Wild, G. E., Afif, W., Bitton, A., Bessissow, T., Brassard, P. & Lakatos, P. L. (2022). Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996-2015. Journal of clinical medicine, vol. 11.
- Isnard, S., Fombuena, B., Ouyang, J., Royston, L., Lin, J., Bu, S., Sheehan, N., Lakatos, P. L., Bessissow, T., Chomont, N., Klein, M., Lebouché, B., Costiniuk, C. T., Routy, B., Marette, A., Routy, J.-P. & Camu Camu Study Group (2022). Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032). BMJ open, vol. 12, p. e053081.
- Wetwittayakhlang, P., Lontai, L., Gonczi, L., Golovics, P. A., Hahn, G. D., Bessissow, T. & Lakatos, P. L. (2021). Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?. Journal of clinical medicine, vol. 10.
- Wetwittayakhlang, P., Albader, F., Golovics, P. A., Hahn, G. D., Bessissow, T., Bitton, A., Afif, W., Wild, G. & Lakatos, P. L. (2021). Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. Canadian journal of gastroenterology & hepatology, vol. 2021, p. 7591141.
- Wetwittayakhlang, P., Golovics, P. A., Afif, W., Bessissow, T. & Lakatos, P. L. (2021). Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis. ACG case reports journal, vol. 8, p. e00678.
- Battat, R., Qatomah, A., Kopylov, U., Wyse, J., Cohen, A., Afif, W., Lakatos, P. L., Seidman, E., Bitton, A. & Bessissow, T. (2022). Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease. Journal of clinical gastroenterology, vol. 56, p. e166-e170.
See also
